Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000034

President & CEO acquired 81,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hirsch Andrew · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-15 Grant or award : show line 1 in the form +81,600 108,606 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-15 Grant or award : show line 2 in the form Stock Option (Right to Buy) +367,200 367,200 D
Loading xslF345X03/wf-form4_167649743141884.xml…